Tiny titin mutation linked to developmental heart defects and adult atrial fibrillation

We can talk about the right way to invest your money all day long. But what is the point of investing if not to finally

Spring­Works Ther­a­peu­tics won FDA ap­proval for its desmoid tu­mor treat­ment Og­siveo on Mon­day, fol­low­ing a three-month reg­u­la­to­ry hic­cup. Desmoid tu­mors are rare but lo­cal­ly ag­gres­sive